DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ribavirin (Ribavirin) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Death (161)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ribavirin death. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 161   Next >>

Possible Ribavirin side effects in

Reported by a consumer/non-health professional from Brazil on 2012-08-23

Patient:

Reactions: Pneumonia, Nausea, Drug Ineffective, Urine Output Decreased, Headache, Varices Oesophageal, Diarrhoea, Blood Pressure Inadequately Controlled, Upper Gastrointestinal Haemorrhage, Septic Shock, Acute Respiratory Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
Ribavirin
    Dosage: unk

Victrelis
    Dosage: unk
    Start date: 2012-02-01

Other drugs received by patient: Interferon (Unspecified)



Possible Ribavirin side effects in 47 year old female

Reported by a health professional (non-physician/pharmacist) from Morocco on 2012-08-23

Patient: 47 year old female

Reactions: Weight Decreased, Angiotensin Converting Enzyme Increased, Subcutaneous Nodule, Aphasia, Coma, Viith Nerve Paralysis, Brain Oedema, Sarcoidosis, Acute Respiratory Failure, Lethargy, Dyspnoea, Neurological Decompensation, Lung Neoplasm, Sensation of Heaviness, Rash, Granuloma, Lymphadenopathy Mediastinal, Cerebral Sarcoidosis, Pleocytosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Dosage: 180 ug, once a week

Ribavirin
    Dosage: 400 mg, bid
    Indication: Hepatitis C

Other drugs received by patient: Prednisolone; Prednisolone; Methylprednisolone



Possible Ribavirin side effects in

Reported by a consumer/non-health professional from Germany on 2012-08-22

Patient:

Reactions: Hepatorenal Syndrome, Sepsis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Citalopram Hydrobromide

Peginterferon Alfa-2A
    Dosage: 180 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-01-05

Ribavirin
    Dosage: 800 mg, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-05

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-02



Possible Ribavirin side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20

Patient:

Reactions: Anaemia, Cerebrovascular Accident

Adverse event resulted in: death

Drug(s) suspected as cause:
Pegasys
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Indication: Product Used FOR Unknown Indication



Possible Ribavirin side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20

Patient: male

Reactions: Abdominal Pain, Dyspnoea, Ileus

Adverse event resulted in: death

Drug(s) suspected as cause:
Cozaar
    Indication: Product Used FOR Unknown Indication

Pegasys
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Incivek



Possible Ribavirin side effects in

Reported by a individual with unspecified qualification from Korea, Republic of on 2012-08-15

Patient:

Reactions: Major Depression

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Boceprevir
    Dosage: 12 df, tid
    Administration route: Oral
    Start date: 2012-05-03
    End date: 2012-05-30

Boceprevir
    Dosage: 12 df, tid
    Administration route: Oral
    Start date: 2012-05-03
    End date: 2012-05-30

Boceprevir
    Dosage: 12 df, tid
    Administration route: Oral
    Start date: 2012-05-03
    End date: 2012-05-30

Boceprevir
    Dosage: 12 df, tid
    Administration route: Oral
    Start date: 2012-05-03
    End date: 2012-05-30

PEG-Intron
    Dosage: 1 df, qw
    Indication: Hepatitis C
    Start date: 2012-04-05
    End date: 2012-05-30

Ribavirin
    Dosage: 5 df, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-05
    End date: 2012-05-30

Ribavirin
    Dosage: 5 df, bid
    Administration route: Oral
    Start date: 2012-04-05
    End date: 2012-05-30



Possible Ribavirin side effects in

Reported by a physician from United States on 2012-08-13

Patient:

Reactions: Pancreatitis

Adverse event resulted in: death

Drug(s) suspected as cause:
Incivek
    Indication: Hepatitis C

Pegasys
    Indication: Hepatitis C

Ribavirin
    Indication: Hepatitis C



Possible Ribavirin side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Abdominal Pain, Dyspnoea, Ileus

Adverse event resulted in: death

Drug(s) suspected as cause:
Cozaar
    Indication: Product Used FOR Unknown Indication

Pegasys
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Telaprevir



Possible Ribavirin side effects in female

Reported by a physician from United States on 2012-08-10

Patient: female, weighing 115.0 kg (253.0 pounds)

Reactions: Multi-Organ Failure, Emphysematous Cystitis, Urinary Tract Infection, Sepsis, Ascites

Adverse event resulted in: death

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2010-12-23
    End date: 2011-01-13

Pegasys
    Start date: 2010-11-05

Ribavirin
    Indication: Hepatitis C
    Start date: 2010-11-05

Other drugs received by patient: Lisinopril; Glipizide; Fluoxetine HCL; Spironolactone; Propranolol; Omeprazole; Glipizide; Fosamax



Possible Ribavirin side effects in

Reported by a physician from Germany on 2012-08-09

Patient:

Reactions: Mallory-Weiss Syndrome, Bile Duct Stent Insertion, Peritonitis Bacterial, Bile Duct Stone, Hepatic Neoplasm Malignant, Portal Vein Thrombosis, Cholecystitis, Hepatic Cirrhosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Ferrous Sulfate TAB
    Dosage: 100 mg, qd
    Administration route: Oral
    Indication: Iron Deficiency
    Start date: 2010-11-01

Peginterferon Alfa-2B
    Dosage: 105 microgram, qw
    Indication: Hepatitis C
    Start date: 2011-03-18
    End date: 2012-02-17

Ribavirin
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-03-18
    End date: 2011-12-31

Ribavirin
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2012-01-03
    End date: 2012-02-17

Other drugs received by patient: Enoxaparin Sodium; Pantoprazole; Hepa-Merz; Dipyrone INJ; Humatin



Possible Ribavirin side effects in male

Reported by a individual with unspecified qualification from France on 2012-08-09

Patient: male, weighing 61.0 kg (134.2 pounds)

Reactions: Tooth Disorder

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

PEG-Intron
    Dosage: 30 ?g, qw
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Peginterferon Alfa-2B
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Peginterferon Alfa-2B
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Placebo
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Placebo
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Ribavirin
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Ribavirin
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22



Possible Ribavirin side effects in 50 year old

Reported by a physician from Germany on 2012-08-08

Patient: 50 year old

Reactions: Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Indication: Hepatitis C

Ribavirin
    Indication: Hepatitis C



Possible Ribavirin side effects in female

Reported by a physician from Germany on 2012-08-06

Patient: female

Reactions: Intestinal Ischaemia, Anaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Indication: Hepatitis C

Ribavirin
    Indication: Hepatitis C



Possible Ribavirin side effects in

Reported by a individual with unspecified qualification from France on 2012-08-03

Patient:

Reactions: Lung Disorder, Haemolytic Anaemia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Boceprevir
    Dosage: 800 mg, tid
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-06-22

Neorecormon
    Dosage: 30000 iu, biw
    Indication: Anaemia
    Start date: 2012-04-26
    End date: 2012-06-22

Peginterferon Alfa-2B
    Dosage: 80 ?g, qw
    Indication: Hepatitis C
    Start date: 2012-03-16
    End date: 2012-06-22

Ribavirin
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2012-03-16
    End date: 2012-06-22

Ribavirin
    Dosage: 600 mg, qd
    Start date: 2012-06-07

Ribavirin
    Dosage: 400 mg, qd
    Start date: 2012-06-20

Other drugs received by patient: Acetaminophen; Isentress; Raltegravir; Raltegravir; Acetaminophen; Emtriva; Celluvisc; Carbohydrates (Unspecified) (+) FAT (Unspecified) (+) Minerals (Unspec; Viread; Mycoster; Carbohydrates (Unspecified) (+) FAT (Unspecified) (+) Minerals (Unspec; Emtriva; Viread; Mycoster; Celluvisc; Drospirenone and Ethinyl Estradiol; Drospirenone and Ethinyl Estradiol; Dexeryl Tablets; Dexeryl Tablets



Possible Ribavirin side effects in

Reported by a consumer/non-health professional from Brazil on 2012-08-02

Patient:

Reactions: Foetal Exposure During Pregnancy, Cardiac Operation, Heart Disease Congenital

Adverse event resulted in: death

Drug(s) suspected as cause:
Ribavirin

Other drugs received by patient: Pegasys; Lisador; Dramin



Possible Ribavirin side effects in

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-02

Patient:

Reactions: Confusional State, Anaemia, Ketoacidosis, Ascites, Loss of Consciousness, Haemoglobin Decreased, Multi-Organ Failure, Renal Failure, Platelet Count Decreased, Septic Shock, Blood Glucose Increased

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Pegasys
    Dosage: 180 ?g, qw
    Indication: Hepatitis C
    Start date: 2011-11-07
    End date: 2012-03-13

Ribavirin
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-07
    End date: 2012-03-13

Victrelis
    Dosage: 800 mg, q8h
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-05
    End date: 2012-03-13

Other drugs received by patient: Glyburide; Metformin Hydrochloride; Eprex; Nadolol; Diazepam; Spironolactone; Lasix



Possible Ribavirin side effects in 57 year old male

Reported by a physician from United States on 2012-07-31

Patient: 57 year old male

Reactions: Death, Tubulointerstitial Nephritis, Renal Failure, Sepsis, Rash

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Allopurinol
    Indication: Hepatitis C

Pegasys
    Indication: Hepatitis C

Ribavirin
    Indication: Hepatitis C

Telaprevir
    Indication: Hepatitis C



Possible Ribavirin side effects in male

Reported by a physician from United States on 2012-07-30

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-07-08
    End date: 2011-09-01

Ribavirin
    Dosage: 600 mg once and 400 mg once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-07-08
    End date: 2011-09-01



Possible Ribavirin side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27

Patient:

Reactions: Haematochezia, Haemoglobin Decreased, Abdominal Discomfort, Fatigue, RED Blood Cell Count Decreased, Haemorrhoids, Flatulence, Platelet Count Decreased, Memory Impairment, Blood Pressure Decreased, Abdominal Pain Upper, Faeces Discoloured

Adverse event resulted in: death

Drug(s) suspected as cause:
Ribavirin
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-05-14

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-06-11

Other drugs received by patient: Pegasys



Possible Ribavirin side effects in

Reported by a physician from Germany on 2012-07-27

Patient:

Reactions: Mallory-Weiss Syndrome, Bile Duct Stent Insertion, Peritonitis Bacterial, Bile Duct Stone, Hepatic Neoplasm Malignant, Portal Vein Thrombosis, Cholecystitis, Hepatic Cirrhosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Ferrous Sulfate TAB
    Dosage: 100 mg, qd
    Administration route: Oral
    Indication: Iron Deficiency
    Start date: 2010-11-01

Peginterferon Alfa-2B
    Dosage: 105 microgram, qw
    Indication: Hepatitis C
    Start date: 2011-03-18
    End date: 2012-02-17

Ribavirin
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2012-01-03
    End date: 2012-02-17

Ribavirin
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-03-18
    End date: 2011-12-31

Other drugs received by patient: Pantoprazole; Dipyrone INJ; Humatin; Hepa-Merz; Enoxaparin Sodium



Possible Ribavirin side effects in

Reported by a individual with unspecified qualification from France on 2012-07-26

Patient:

Reactions: Tooth Disorder

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded Post Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Blinded PRE Trial Therapy
    Dosage: 800 mg, qd
    Start date: 2007-10-18
    End date: 2010-07-22

PEG-Intron
    Dosage: 30 ?g, qw
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Peginterferon Alfa-2B
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Placebo
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22

Ribavirin
    Dosage: 800 mg, qd
    Indication: Hepatitis C
    Start date: 2007-10-18
    End date: 2010-07-22



Possible Ribavirin side effects in

Reported by a individual with unspecified qualification from France on 2012-07-25

Patient:

Reactions: Pyelonephritis Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Boceprevir
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-07

Peginterferon Alfa-2B
    Dosage: 80 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-02-08

Ribavirin
    Dosage: 400 mg, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-08

Other drugs received by patient: Isentress; Truvada; Truvada; Isentress



Possible Ribavirin side effects in

Reported by a individual with unspecified qualification from Germany on 2012-07-25

Patient:

Reactions: Bile Duct Stent Insertion, Mallory-Weiss Syndrome, Hepatic Neoplasm Malignant, Peritonitis Bacterial, Bile Duct Stone, Portal Vein Thrombosis, Cholecystitis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Ferrous Sulfate TAB
    Dosage: 100 mg, qd
    Administration route: Oral
    Indication: Iron Deficiency
    Start date: 2010-11-01

Peginterferon Alfa-2B
    Dosage: 105 microgram, qw
    Indication: Hepatitis C
    Start date: 2011-03-18
    End date: 2012-02-17

Ribavirin
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2012-01-03
    End date: 2012-02-17

Ribavirin
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-03-18
    End date: 2011-12-31

Other drugs received by patient: Pantoprazole; Enoxaparin Sodium; Dipyrone INJ



Possible Ribavirin side effects in male

Reported by a physician from Mexico on 2012-07-23

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C

Ribavirin
    Indication: Hepatitis C



Possible Ribavirin side effects in

Reported by a consumer/non-health professional from United States on 2012-07-20

Patient:

Reactions: Hypogeusia, Glossodynia, Tinnitus, Hypoaesthesia Oral

Adverse event resulted in: death

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C

Ribavirin
    Indication: Hepatitis C

Victrelis
    Dosage: 800 mg, q8h
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-11



Possible Ribavirin side effects in 62 year old male

Reported by a pharmacist from United States on 2012-07-19

Patient: 62 year old male, weighing 76.0 kg (167.2 pounds)

Reactions: Interstitial Lung Disease, Respiratory Failure, Condition Aggravated

Adverse event resulted in: death

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Dosage: 180 ml qweek sq
    Indication: Hepatitis C
    Start date: 2012-01-03
    End date: 2012-05-10

Ribavirin
    Dosage: mg po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-03
    End date: 2012-05-10



Possible Ribavirin side effects in

Reported by a individual with unspecified qualification from France on 2012-07-19

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Ribavirin
    Dosage: 1000 mg, qw
    Indication: Hepatitis C
    Start date: 2012-03-27

Viraferonpeg
    Dosage: 100 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-03-27



Possible Ribavirin side effects in male

Reported by a physician from Mexico on 2012-07-19

Patient: male

Reactions: Gastrointestinal Haemorrhage

Adverse event resulted in: death

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C

Ribavirin
    Indication: Hepatitis C



Possible Ribavirin side effects in 43 year old male

Reported by a physician from United Kingdom on 2012-07-17

Patient: 43 year old male, weighing 68.0 kg (149.6 pounds)

Reactions: Hypoxic-Ischaemic Encephalopathy, Bronchopneumonia, Cardiac Arrest

Adverse event resulted in: death

Drug(s) suspected as cause:
Incivo
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-20

Pegasys
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-20

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18

Other drugs received by patient: Albuterol Sulate; Omeprazole; Dihydrocodeine Bitartrate INJ; Beclomethasone Dipropionate; Diazepam



Possible Ribavirin side effects in

Reported by a consumer/non-health professional from United States on 2012-07-17

Patient:

Reactions: Influenza Like Illness

Adverse event resulted in: death

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 a?g, qw
    Indication: Hepatitis C
    Start date: 2012-01-01

Ribavirin
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Antiviral (Unspecified)



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014